(Q35072249)

6 August 2017

1 reference

title

Megadose transplantation of highly purified haploidentical stem cells: current results and future prospects (English)

1 reference

6 August 2017

2

Thomas Klingebiel

1 reference

6 August 2017

Rupert Handgretinger

1

1 reference

6 August 2017

Peter Lang

series ordinal

3

1 reference

6 August 2017

Paul Gordon

series ordinal

4

1 reference

6 August 2017

Dietrich Niethammer

series ordinal

5

1 reference

6 August 2017

publication date

1 January 2003

1 reference

Pediatric Transplantation

6 August 2017

published in

1 reference

6 August 2017

volume

7 Suppl 3

1 reference

6 August 2017

page(s)

51-55

1 reference

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

High gradient magnetic cell separation with MACS

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Clinical scale isolation of highly purified peripheral CD34+progenitors for autologous and allogeneic transplantation in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Complement-mediated T-cell depletion of bone marrow: comparison of T10B9.1A-31 and Muromonab-Orthoclone OKT3.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

CD34 stem cell dose and development of extensive chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Haploidentical 'megadose' stem cell transplantation in acute leukemia: recommendations for a protocol agreed upon at the Perugia and Chicago meetings.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

CAMPATH-1 antibodies in stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Interleukin-7: master regulator of peripheral T-cell homeostasis?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Interleukin-7: from bench to clinic

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

NK cells: a lesson from mismatched hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.7.S3.7.X

7 January 2021

10.1034/J.1399-3046.7.S3.7.X

Identifiers

DOI

1 reference

6 August 2017

1 reference